Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572247 · ClinicalTrials.gov registry record · NA
The Psychiatric Rehabilitation Approach to Weight Loss
A NA study of Schizophrenic Disorders, sponsored by University of Kansas.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
- 1
- Study location
NCT00572247: Completed NA study of Schizophrenic Disorders, sponsored by University of Kansas.
NCT00572247 is a NA study of Schizophrenic Disorders that has completed, run by University of Kansas. The registered enrollment target is 133 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00572247, a NA study of Schizophrenic Disorders, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of the project is to examine the efficacy of the Psychiatric Rehabilitation Weight Loss program in reduction of weight and body mass index (BMI.
Conditions Studied
Interventions
- BEHAVIORAL Psychiatric Rehabilitation Approach to Weight Loss
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-12 |
| Phase | NA |
What the finished NCT00572247 record still lists
NCT00572247 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Schizophrenic Disorders appearing as the primary indexed condition, and to 1 intervention - of which Psychiatric Rehabilitation Approach to Weight Loss is the first listed.
NCT00572247 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT00572247 about?
NCT00572247 is a clinical study titled "The Psychiatric Rehabilitation Approach to Weight Loss". The primary aim of the project is to examine the efficacy of the Psychiatric Rehabilitation Weight Loss program in reduction of weight and body mass index (BMI.
What is the current status of trial NCT00572247?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2007-01. Estimated completion is 2010-12.
What conditions does trial NCT00572247 study?
This clinical trial studies the following conditions: Schizophrenic Disorders.
What interventions are being tested in trial NCT00572247?
The interventions under investigation include: Psychiatric Rehabilitation Approach to Weight Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT00572247?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00572247 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenic Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00572247's enrollment target sits among peer trials
133 729th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia